Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that health-related quality of life was significantly lower in women with polycystic ovary syndrome, especially those with the anovulatory phenotype, compared to non-PCOS controls attending a tertiary hospital.

This study found that women with PCOS were more likely than women without PCOS to have multiple weight-loss attempts and perceive themselves as overweight, regardless of their actual obesity status.

This study focused on overweight and obese women with polycystic ovary syndrome who underwent lifestyle modification interventions and found notable improvements in BMI, menstrual cycle regularities, hyper-androgenic symptoms, and fertility outcomes, including a 36.2% pregnancy rate post-intervention.

In this study, re-activating SOX9 in adult epidermal stem cells led to a fate switch towards hair follicle stem cell identity, with altered chromatin dynamics and oncogenic activation, contributing insights into developmental processes and cancer pathways.

This study found that women with PCOS reported significant appearance-related distress and social anxiety, especially in social settings.

This study reported that MALDI-TOF Mass Spectrometry profiling demonstrated nearly 100% sensitivity and specificity in detecting adenomyosis and leiomyoma, revealing potential peptide markers for these conditions.

This pilot study found that Optical Coherence Tomography can non-invasively resolve hair follicle density and hair shaft and follicle diameters in patients at varying stages of hair loss.

This study reported that a three-dimensional hydrogel culture system supports the growth and maintenance of distinct dermal papilla cell types, crucial for skin reconstitution assays in neonatal mice.

This study suggests a potential role for systematic scalp examinations in first-degree relatives of patients with pattern cicatricial alopecia.

This study identified that bone marrow-derived CD34⁺ cells act as fibroblast progenitors to enhance tissue regeneration in ischemic limbs by promoting angiogenesis through interactions with macrophages.

This study found that women with PCOS have elevated serum androgen levels throughout adulthood, with these levels decreasing and variations increasing as they approach menopause.

Among reproductive-aged women in Iran, this study found that the prevalence of PCOS varied significantly depending on the diagnostic criteria used, with estimates ranging from 7.1% to 14.6%.

This study found that androgenetic alopecia was the most common cause of hair loss among patients at Sohag University Hospital's hair clinic.

This study found that the ovarian stromal area to total ovarian area ratio alone is not a strong predictor of biochemical hyperandrogenism in Thai women with PCOS, but combining it with clinical hyperandrogenism improves prediction.

In a mouse model of androgenetic alopecia, this study found that a safflower oil body nanoparticle loaded with human fibroblast growth factor 10 significantly improved hair regeneration and reduced associated microinflammation without significant toxicity.

This paper discusses polycystic ovary syndrome with a focus on androgen excess as the primary symptom and notes that insulin resistance may contribute to it in many patients, but provides no new research findings.

This study found that deferoxamine may protect against sensorineural hearing loss by reducing oxidative stress-induced hair cell death through iron chelation and activation of the Nrf2 signaling pathway in lab models.

This study found that sulforaphane and its related compounds may promote hair follicle growth in mice, suggesting their potential as treatment agents for androgenic alopecia.

Recent studies highlighted in this research suggest that alopecia types in men, traditionally thought to affect only certain scalp areas, can also impact the occipital region, which was previously presumed unaffected.

This study found that phenoxyethanol is the most common contact allergen in over-the-counter hair loss products, but its role in the development or exacerbation of frontal fibrosing alopecia remains unclear.

This article discusses the causes of polycystic ovary syndrome, including environmental pollutants, genetics, and oxidative stress, and explains how these factors contribute to symptoms like irregular menstrual cycles and obesity without reporting new clinical results.

This study found that medications including benzodiazepines, quetiapine, and certain alpha-blockers, along with hypertension and short axial length, were independently associated with an increased risk of Intraoperative Floppy Iris Syndrome during cataract surgery.

This article reviews IFAP syndrome, an X-linked genetic disorder characterized by ichthyosis follicularis, alopecia, and photophobia, and reports no new clinical findings.

This study found that combining metformin with myo-inositol improved outcomes for women with Polycystic Ovary Syndrome, resulting in a statistically significant increase in normal ovarian size and higher pregnancy rates compared to treatment with metformin alone.

This study found that Caucasian and Asian women with PCOS in the San Francisco Bay Area had a similar prevalence of androgen excess, including hirsutism, across most measures.

This article discusses the characteristics and potential consequences of polycystic ovarian syndrome, including its effects on fertility and risk for other health conditions, but it reports no new findings.

In this study, researchers found that overexpressing SOX2 in colorectal cancer cell lines can cause DNA damage and cell death, while repressing it reduces tumor growth and cell aggressiveness.

This review discusses the genetic basis and familial patterns of polycystic ovary syndrome, noting a strong familial component but inconclusive genetic patterns; it reports no new empirical findings.

In this study, PCOS was found to be highly prevalent among urban, middle socioeconomic status women aged 21 to 30, with common symptoms including oligomenorrhea, weight gain, infertility, hirsutism, and acne.

This review discusses the potential male equivalent of polycystic ovary syndrome, examining early-onset androgenic alopecia as a marker and current research on risks and diagnostic recommendations, but it reports no new results.